Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

Search Results for 'Paladin, Apeiron in Neuroblastoma Pact'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By WITec GmbH
By Bob Muschert, Global Sales & Business Development Director
Published January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa Read More »
By Anna Shagako, Clinical Operations Head
By Mr. Deepak Bahri, President
By Jerome BESSE, CEO
By Chris Landeg, Director of Business Development
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On